Clearance of RhodopsinP23H aggregates requires the ERAD effector VCP

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 3, 2010, Pages 424-434

  Griciuc, Ana ^a   Aron, Liviu ^b   Piccoli, Giovanni ^a   Ueffing, Marius ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

ATPase; ERAD; Proteasome; Retinitis pigmentosa; Rhodopsin; VCP

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CHAPERONE; DNA; PROTEASOME; PROTEIN VCP; RHODOPSIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR CLONING; NEUROBLASTOMA CELL; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RETINA CELL; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL CYCLE PROTEINS; CELLS, CULTURED; ENDOPLASMIC RETICULUM; HUMANS; MICE; MOLECULAR CHAPERONES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS; RETINA; RETINITIS PIGMENTOSA; RHODOPSIN;

MAMMALIA;

EID: 77249177476     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.01.008     Document Type: Article

References (51)

1. Chapple J.P., Grayson C., Hardcastle A.J., Saliba R.S., van der Spuy J., and Cheetham M.E. Unfolding retinal dystrophies: a role for molecular chaperones?. Trends Mol. Med. 7 (2001) 414-421
2. Farrar G.J., Kenna P.F., and Humphries P. On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J. 21 (2002) 857-864
3. Kennan A., Aherne A., and Humphries P. Light in retinitis pigmentosa. Trends Genet. 21 (2005) 103-110
4. Mendes H.F., van der Spuy J., Chapple J.P., and Cheetham M.E. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol. Med. 11 (2005) 177-185
5. Naash M.I., Hollyfield J.G., al-Ubaidi M.R., and Baehr W. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5499-5503
6. Sung C.H., Schneider B.G., Agarwal N., Papermaster D.S., and Nathans J. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 8840-8844
7. Illing M.E., Rajan R.S., Bence N.F., and Kopito R.R. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 277 (2002) 34150-34160
8. Pro23His human retinitis pigmentosa. Hum. Mol. Genet. 14 (2005) 2547-2557
9. Saliba R.S., Munro P.M., Luthert P.J., and Cheetham M.E. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J. Cell Sci. 115 (2002) 2907-2918
10. Li Z.Y., Wong F., Chang J.H., Possin D.E., Hao Y., Petters R.M., and Milam A.H. Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 39 (1998) 808-819
11. Green E.S., Menz M.D., LaVail M.M., and Flannery J.G. Characterization of rhodopsin mis-sorting and constitutive activation in a transgenic rat model of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1546-1553
12. Alfinito P.D., and Townes-Anderson E. Activation of mislocalized opsin kills rod cells: a novel mechanism for rod cell death in retinal disease. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5655-5660
13. Colley N.J., Cassill J.A., Baker E.K., and Zuker C.S. Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration. Proc. Natl. Acad. Sc. U. S. A. 92 (1995) 3070-3074
14. Kurada P., and O'Tousa J.E. Retinal degeneration caused by dominant rhodopsin mutations in Drosophila. Neuron 14 (1995) 571-579
15. Kurada P., Tonini T.D., Serikaku M.A., Piccini J.P., and O'Tousa J.E. Rhodopsin maturation antagonized by dominant rhodopsin mutants. Vis. Neurosci. 15 (1998) 693-700
16. Rajan R.S., and Kopito R.R. Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J. Biol. Chem. 280 (2005) 1284-1291
17. Römisch K. Endoplasmic reticulum-associated degradation. Annu. Rev. Cell Dev. Biol. 21 (2005) 435-456
18. Vembar S.S., and Brodsky J.L. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 9 (2008) 944-957
19. Ye Y., Meyer H.H., and Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414 (2001) 652-656
20. Wang Q., Song C., and Li C.C. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J. Struct. Biol. 146 (2004) 44-57
21. Zhang X., Shaw A., Bates P.A., Newman R.H., Gowen B., Orlova E., Gorman M.A., Kondo H., Dokurno P., Lally J., et al. Structure of the AAA ATPase p97. Mol. Cell 6 (2000) 1473-1484
22. Song C., Wang Q., and Li C.C. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J. Biol. Chem. 278 (2003) 3648-3655
23. Alexandru G., Graumann J., Smith G.T., Kolawa N.J., Fang R., and Deshaies R.J. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 134 (2008) 804-816
24. Meyer H.H., Wang Y., and Warren G. Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J. 21 (2002) 5645-5652
25. Ye Y., Meyer H.H., and Rapoport T.A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 162 (2003) 71-84
26. Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., O'Riordan C.R., and Smith A.E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63 (1990) 827-834
27. Vij N., Fang S., and Zeitlin P.L. Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications. J. Biol. Chem. 281 (2006) 17369-17378
28. Schwieger I., Lautz K., Krause E., Rosenthal W., Wiesner B., and Hermosilla R. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors. Mol. Pharmacol. 73 (2008) 697-708
29. Orr H.T., and Zoghbi H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30 (2007) 575-621
30. Johnson B.S., Snead D., Lee J.J., McCaffery J.M., Shorter J., and Gitler A.D. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284 (2009) 20329-20339
31. Boeddrich A., Gaumer S., Haacke A., Tzvetkov N., Albrecht M., Evert B.O., Müller E.C., Lurz R., Breuer P., Schugardt N., et al. An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J. 25 (2006) 1547-1558
32. Gitcho M.A., Strider J., Carter D., Taylor-Reinwald L., Forman M.S., Goate A.M., and Cairns N.J. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death. J. Biol. Chem. 284 (2009) 12384-12398
33. Mizuno Y., Hori S., Kakizuka A., and Okamoto K. Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci. Lett. 343 (2003) 77-80
34. Meusser B., Hirsch C., Jarosch E., and Sommer T. ERAD: the long road to destruction. Nat. Cell Biol. 7 (2005) 766-772
35. Wahlman J., DeMartino G.N., Skach W.R., Bulleid N.J., Brodsky J.L., and Johnson A.E. Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system. Cell 129 (2007) 943-955
36. Mendes H.F., and Cheetham M.E. Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa. Hum. Mol. Genet. 17 (2008) 3043-3054
37. Ballar P., Shen Y., Yang H., and Fang S. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation. J. Biol. Chem. 281 (2006) 35359-35368
38. Wang Q., Song C., and Li C.C. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem. Biophys. Res. Commun. 300 (2003) 253-260
39. Ballar P., Zhong Y., Nagahama M., Tagaya M., Shen Y., and Fang S. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation. J. Biol. Chem. 282 (2007) 33908-33914
40. DeLaBarre B., Christianson J.C., Kopito R.R., and Brunger A.T. Central pore residues mediate the p97/VCP activity required for ERAD. Mol. Cell 22 (2006) 451-462
41. Kobayashi T., Tanaka K., Inoue K., and Kakizuka A. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J. Biol. Chem. 277 (2002) 47358-47365
42. Weihl C.C., Dalal S., Pestronk A., and Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 15 (2006) 189-199
43. Hirabayashi M., Inoue K., Tanaka K., Nakadate K., Ohsawa Y., Kamei Y., Popiel A.H., Sinohara A., Iwamatsu A., Kimura Y., et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 8 (2001) 977-984
44. Wójcik C., Yano M., and DeMartino G.N. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysi. J. Cell Sci. 117 (2004) 281-292
45. Vandermoere F., El Yazidi-Belkoura I., Slomianny C., Demont Y., Bidaux G., Adriaenssens E., Lemoine J., and Hondermarck H. The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J. Biol. Chem. 281 (2006) 14307-14313
46. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., Shokat K.M., Lavail M.M., and Walter P. IRE1 signaling affects cell fate during the unfolded protein response. Science 318 (2007) 944-949
47. Satoh A.K., and Ready D.F. Arrestin1 mediates light-dependent rhodopsin endocytosis and cell survival. Curr. Biol. 15 (2005) 1722-1733
48. Ward C.L., Omura S., and Kopito R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83 (1995) 121-127
49. Kang M.J., and Ryoo H.D. Suppression of retinal degeneration in Drosophila by stimulation of ER-associated degradation. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 17043-17048
50. Kosmaoglou M., Kanuga N., Aguilà M., Garriga P., and Cheetham M.E. A dual role for EDEM1 in the processing of rod opsin. J. Cell Sci. 122 (2009) 4465-4472
51. Mosharov E.V., Larsen K.E., Kanter E., Phillips K.A., Wilson K., Schmitz Y., Krantz D.E., Kobayashi K., Edwards R.H., and Sulzer D. Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62 (2009) 218-229